ArabianBusiness.com - Middle East Business News
Sunday, 22 November 2009 15:12 UAE time

YOUR DIRECTORY /

| Share |

Low-carb diets show longer-term perks

by ArabianBusiness.com staff writer  on Saturday, 26 July 2008
Study subjects were able to reduce their medication dosages after six months on the diet.

In obese type 2 diabetic patients, a low-carbohydrate diet with some calorie restriction can have lasting benefits on body weight and glycemic control, a study has reported.

Swedish researchers previously reported that 16 obese patients with type 2 diabetes who followed a 20% carbohydrate diet demonstrated significantly better glycemic control and body weight over six months, compared to 15 patients following a 55-60% carbohydrate diet.

Follow-up data at 22 months for the low-carbohydrate group showed "stable improvement" of body weight and glycemic control, wrote Dr Jorgen Vesti Nielsen and Dr Eva A. Joensson in the journal Nutrition and Metabolism.

Story continues below
advertisement

At six months, mean body weight among the low-carbohydrate group was 89.2 kg and at 22 months it was 92.0 kg, compared to 100.6 kg at the start of the trial.

"It is significant," the authors note, "that 44% of the patients have had a stable weight or have reduced it further and all but one had a lower weight at 22 months than at the beginning of the study."

Initial HbA1c was 8.0% in the low-carbohydrate group. After six and 12 months, HbA1c had improved to 6.6% and 7.0%, respectively. At 22 months it was still reduced among subjects, at 6.9%.

After six months on the low-carb diet, two of five patients using sulfonylurea had discontinued this medication and three were able to lower the dosage. Similarly, three of 11 insulin-treated patients discontinued insulin and the mean insulin requirement among the other eight had fallen significantly from 60 IU/day to 18 IU/day.

"Several recent reviews have made the case for reducing the carbohydrate load in type 2 diabetes...the diet presented here is clearly effective in many obese people with type 2 diabetes," the authors write. "Because of its effectiveness it should be used with close clinical supervision in patients on insulin or oral hypoglycemic agents."

| Share |


READERS' COMMENTS

Disclaimer: The views expressed here by our readers are not necessarily shared by ArabianBusiness.com or its employees.

Click here to post a comment


Add your Comment
All posts are sent to the administrator for review and are published only after approval. ArabianBusiness.com reserves the right to remove any comment at any time for any reason. Please keep your responses appropriate and on topic.
Arabian Business would like to point out that only comments relevant to the story will be published. Any containing personal insults or inappropriate language will not be approved.
Name *
Remember me on this computer
Email *
(Your email address will not be published)
City
Country
Subject *
Comment *
Notify me of further comments


Please click post only once - your comment will not be published immediately.


MORE FROM ARABIANBUSINESS.COM

From  Current Issue

SHARE PRICE CHECK

RELATED LINKS

  1. Medical Times Middle East»

 EMAIL ALERTS

  1. Medical Times Middle East

  2. Healthcare


Tell us your story

READER COMMENTS

  1. The Roubini Vs Rogers debate 04
    22 Nov ' 09 at 14:44
    Simon, I agree with everything you say. The paper gold games of Comex and the gold fractional reserve banking system of the LBMA are...   More  »
  2. RTA to lease last batch of retail outlets on Red Line 04
    22 Nov ' 09 at 14:54
    Guys not that I am against these Retail Outlets but I was wondering how many of the metro users actually use these outlets?Any one of...   More  »
  3. Merger technical talks to conclude in a month - Emaar 03
    22 Nov ' 09 at 12:33
    Dubai needs is Antitrust & Trade Practices law in place to go forward.Too many people have burnt their fingers including large...   More  »

Read all user comments >

Gitex 2009

MORE FROM ARABIANBUSINESS.COM